UB Paderborn / Katalog / Suche / in CDI

1 – 17 von 17

Sortiert nach

FACTORS CONTRIBUTING TO PERITONEAL TISSUE REMODELING IN PERITONEAL DIALYSIS

Peritoneal dialysis international, 2009-11, Vol.29 (6), p.605-617

2009

Volltextzugriff (PDF)

Determination of fibroblast growth factor 23

Annals of clinical biochemistry, 2009-07, Vol.46 (Pt 4), p.338

2009

Volltextzugriff (PDF)

Higher plasma levels of von Willebrand factor and C-reactive protein during a peritoneal dialysis regimen with less glucose and glucose degradation products

Peritoneal dialysis international, 2013-03, Vol.33 (2), p.208-212

2013

Volltextzugriff (PDF)

Pharmacologic Targets and Peritoneal Membrane Remodeling

Peritoneal dialysis international, 2014-01, Vol.34 (1), p.114-123

2014

Volltextzugriff (PDF)

“NEPP” Peritoneal Dialysis Regimen Has Beneficial Effects on Plasma CEL and 3-DG, But Not Pentosidine, CML, and MGO

Peritoneal dialysis international, 2012-01, Vol.32 (1), p.45-54

2012

Volltextzugriff (PDF)

A Peritoneal Dialysis Regimen Low in Glucose and Glucose Degradation Products Results in Increased Cancer Antigen 125 and Peritoneal Activation

Peritoneal dialysis international, 2012-05, Vol.32 (3), p.305-315

2012

Volltextzugriff (PDF)

LONG-TERM INTERVENTION WITH HEPARINS IN A RAT MODEL OF PERITONEAL DIALYSIS

Peritoneal dialysis international, 2009-01, Vol.29 (1), p.26-35

2009

Volltextzugriff (PDF)

Single exposure of mesothelial cells to glucose degradation products (GDPs) yields early advanced glycation end-products (AGEs) and a proinflammatory response

Peritoneal dialysis international, 2003-05, Vol.23 (3), p.213-221

2003

Volltextzugriff (PDF)

Initiating capd with a regimen low in glucose and glucose degradation products, with icodextrin and amino acids (NEPP) is safe and efficacious

Peritoneal dialysis international, 2005-02, Vol.25 (3_suppl), p.S64-S68

2005

Volltextzugriff (PDF)

Better preservation of the peritoneum in rats exposed to amino acid-based peritoneal dialysis fluid

Peritoneal dialysis international, 2005-01, Vol.25 (1), p.58-67

2005

Volltextzugriff (PDF)

Increased leukocyte rolling in newly formed mesenteric vessels in the rat during peritoneal dialysis

Peritoneal dialysis international, 2002-11, Vol.22 (6), p.655-662

2002

Volltextzugriff (PDF)

Intraperitoneal ciprofloxacin and rifampicin versus cephradine as initial treatment of (C)APD-related peritonitis: a prospective randomized multicenter comparison (CIPPER trial)

Peritoneal dialysis international, 2001-09, Vol.21 (5), p.480-486

2001

Volltextzugriff (PDF)

Comparison of the AT1-receptor blockers candesartan, irbesartan and losartan for inhibiting renal microvascular constriction

Journal of the renin-angiotensin-aldosterone system, 2001-03, Vol.2 (1_suppl), p.S204-S210

2001

Volltextzugriff (PDF)

Folic acid treatment of hyperhomocysteinemia in peritoneal dialysis patients: no change in endothelial function after long-term therapy

Peritoneal dialysis international, 1998-05, Vol.18 (3), p.282

1998

Volltextzugriff (PDF)

Better preservation of the peritoneum in rats exposed to amino acid-based peritoneal dialysis fluid. Commentary

Peritoneal dialysis international, 2005, Vol.25 (1), p.58-67

2005

Volltextzugriff (PDF)

Accumulation of omental mast cells during peritoneal dialysis

Peritoneal dialysis international, 2001-01, Vol.21 Suppl 3 (3_suppl), p.S373-376

2001

Volltextzugriff (PDF)

Railway stations and urban dynamics

Environment and planning. A, 2007-09, Vol.39 (9), p.2048-2138

2007

Volltextzugriff (PDF)

1 – 17 von 17

Suche als RSS-Feed

Aktive Filter

Zeitschrift / SeriePalliative Medicine

KollektionSAGE Complete

Nur zeigenGeprüft (Peer-Review)

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Mit Volltextzugriff
(15)

Publikationsform

Artikel
(17)

Sprache

Englisch
(17)
Japanisch
(4)

Erscheinungsjahr

n.n

Kollektion

1 weiteren anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

3 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

FACTORS CONTRIBUTING TO PERITONEAL TISSUE REMODELING IN PERITONEAL DIALYSIS

Determination of fibroblast growth factor 23

Higher plasma levels of von Willebrand factor and C-reactive protein during a peritoneal dialysis regimen with less glucose and glucose degradation products

Pharmacologic Targets and Peritoneal Membrane Remodeling

“NEPP” Peritoneal Dialysis Regimen Has Beneficial Effects on Plasma CEL and 3-DG, But Not Pentosidine, CML, and MGO

A Peritoneal Dialysis Regimen Low in Glucose and Glucose Degradation Products Results in Increased Cancer Antigen 125 and Peritoneal Activation

LONG-TERM INTERVENTION WITH HEPARINS IN A RAT MODEL OF PERITONEAL DIALYSIS

Single exposure of mesothelial cells to glucose degradation products (GDPs) yields early advanced glycation end-products (AGEs) and a proinflammatory response

Initiating capd with a regimen low in glucose and glucose degradation products, with icodextrin and amino acids (NEPP) is safe and efficacious

Better preservation of the peritoneum in rats exposed to amino acid-based peritoneal dialysis fluid

Increased leukocyte rolling in newly formed mesenteric vessels in the rat during peritoneal dialysis

Intraperitoneal ciprofloxacin and rifampicin versus cephradine as initial treatment of (C)APD-related peritonitis: a prospective randomized multicenter comparison (CIPPER trial)

Comparison of the AT1-receptor blockers candesartan, irbesartan and losartan for inhibiting renal microvascular constriction

Folic acid treatment of hyperhomocysteinemia in peritoneal dialysis patients: no change in endothelial function after long-term therapy

Better preservation of the peritoneum in rats exposed to amino acid-based peritoneal dialysis fluid. Commentary

Accumulation of omental mast cells during peritoneal dialysis

Railway stations and urban dynamics

Aktive Filter

Suchergebnisse filtern